Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma. Journal Articles Unrefereed uri icon

Overview

Published in

  • Cancer Immunity

Time

Date/time value

  • 2003

Additional Document Info

Parent Title

  • Cancer Immun

Volume

  • 3

Number

  • 7

Publisher

  • Academy of Cancer Immunology